Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
538 participants
OBSERVATIONAL
2017-12-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To determine a cut-off value for NEWS score for early readmission
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Warning Systems, Risk of Early Clinical Deterioration
NCT03912701
Usefulness of Early Warning Systems in Detecting Early Clinical Deterioration After Intensive Care Discharge
NCT03910777
Intensive Care Unit Risk Score
NCT04661735
Evaluation of Lab Exams Accuracy in the Intensive Care Unit
NCT06622096
Prediction of Safe Discharge From ICU
NCT05459350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
discharge
patients discharged from icu
readmission
Readmission after 48 hours
discharge
Discharge
readmission
patients readmitted icu in 48 hours after icu discharge
readmission
Readmission after 48 hours
discharge
Discharge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
readmission
Readmission after 48 hours
discharge
Discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stay higher than 48 hours
Exclusion Criteria
* Stay lower than 48 hours
* Intoxication
* Exitus
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hitit University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Selcuk KAYIR
Medical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ozgur Yagan, Assoc.Prof.
Role: STUDY_CHAIR
Hitit universtiy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hitit university
Çorum, Çorum, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.